514 related articles for article (PubMed ID: 28948907)
1. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
Rafiei P; Haddadi A
Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
3. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
4. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer.
Cai J; Qian K; Zuo X; Yue W; Bian Y; Yang J; Wei J; Zhao W; Qian H; Liu B
J Biomater Appl; 2019 May; 33(10):1394-1406. PubMed ID: 30952195
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
6. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
Senthilkumar M; Mishra P; Jain NK
J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
[TBL] [Abstract][Full Text] [Related]
8. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
9. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
10. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
11. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
12. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
14. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
15. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
16. Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile.
Raza K; Kumar N; Misra C; Kaushik L; Guru SK; Kumar P; Malik R; Bhushan S; Katare OP
Int J Biol Macromol; 2016 Jul; 88():206-12. PubMed ID: 27037052
[TBL] [Abstract][Full Text] [Related]
17. Towards rational design of API-poly(D, L-lactide-co-glycolide) based micro- and nanoparticles: The role of API-polymer compatibility prediction.
Iemtsev A; Zumaya ALV; Dinh M; Hassouna F; Fulem M
Int J Pharm; 2024 Jan; 650():123724. PubMed ID: 38123107
[TBL] [Abstract][Full Text] [Related]
18. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
20. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]